Financhill
Back

Santhera Pharmaceuticals Holding AG Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
42

SPHDF
Santhera Pharmaceuticals Holding AG

Last Price:
9.42
Seasonality Move:
8.21%
Sell
44

CRSP
CRISPR Therapeutics AG

Last Price:
43.82
Seasonality Move:
19.76%
Sell
42
Santhera Pharmaceuticals Holding AG (SPHDF) is a Sell

Is Santhera Pharmaceuticals Holding AG a Buy, Sell or Hold?

  • The current Santhera Pharmaceuticals Holding AG [SPHDF] share price is $9.42. The Score for SPHDF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SPHDF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $43.78. The Score for CRSP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPHDF Stock Price Chart

What is Santhera Pharmaceuticals Holding AG's stock price today?

  • The Santhera Pharmaceuticals Holding AG share price today is $9.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPHDF is experiencing slight buying pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $43.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight selling pressure.

SPHDF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 0 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.79 - 11.97) Sell
Bollinger Bands (100): (10.84 - 12.14) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.57 Sell
Relative Strength Index (14 RSI): 37.78 Sell
Chaikin Money Flow: -817353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.65 - 52.01) Sell
Bollinger Bands (100): (45.63 - 51.81) Sell

SPHDF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.42 Sell
20-day SMA: 10.67 Sell
50-day SMA: 11.29 Sell
200-day SMA: 11.6 Sell
8-day EMA: 9.66 Sell
20-day EMA: 10.35 Sell
50-day EMA: 11.01 Sell
200-day EMA: 11.4 Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.56 Sell
20-day SMA: 48.98 Sell
50-day SMA: 48.62 Sell
200-day SMA: 54.99 Sell
8-day EMA: 47.66 Sell
20-day EMA: 48.82 Sell
50-day EMA: 48.97 Sell
200-day EMA: 52.8 Sell

Santhera Pharmaceuticals Holding AG Earnings Growth & SPHDF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.

Santhera Pharmaceuticals Holding AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):